J.A. Kuivenhoven

886 citations

18 papers · 595 indexed · h-index 11

Co-authors: John J.P. Kastelein J. Wouter Jukema S. Matthijs Boekholdt Sheila Bingham Robert Luben Kay‐Tee Khaw Nicholas J. Wareham Nicholas Day
Topics: Lipoproteins and Cardiovascular Health (11 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers)Cholesterol and Lipid Metabolism (4 papers)
Cited by: Endocrinology, Diabetes and Metabolism Surgery Cancer Research
Journals: Circulation Journal of Clinical Investigation Journal of Lipid Research
Partner nations: Netherlands United States United Kingdom

In The Last Decade

J.A. Kuivenhoven

18 papers receiving 583 citations

Peers

Countries citing papers authored by J.A. Kuivenhoven

Since Specialization

Citations

This map shows the geographic impact of J.A. Kuivenhoven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.A. Kuivenhoven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.A. Kuivenhoven more than expected).

Fields of papers citing papers by J.A. Kuivenhoven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.A. Kuivenhoven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.A. Kuivenhoven. The network helps show where J.A. Kuivenhoven may publish in the future.

Co-authorship network of co-authors of J.A. Kuivenhoven

This figure shows the co-authorship network connecting the top 25 collaborators of J.A. Kuivenhoven. A scholar is included among the top collaborators of J.A. Kuivenhoven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.A. Kuivenhoven. J.A. Kuivenhoven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Proteoglycan 4 regulates macrophage function without altering atherosclerotic lesion formation in a murine bone marrow-specific deletion model 2018 ·Atherosclerosis ·(unknown),Menno Hoekstra,Stefan R. Havik,Peter J. van Santbrink,Geesje M. Dallinga‐Thie,J.A. Kuivenhoven,Janine J. Geerling,Miranda Van Eck	13
2	The Promise of Cholesteryl Ester Transfer Protein (CETP) Inhibition in the Treatment of Cardiovascular Disease 2013 ·Current Pharmaceutical Design ·(unknown),J.A. Kuivenhoven,Erik S.G. Stroes	21
3	32 TRIGLYCERIDE-RICH LIPOPROTEINS AND HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN PATIENTS AT HIGH RISK OF CARDIOVASCULAR DISEASE: EVIDENCE AND GUIDANCE FOR MANAGEMENT 2011 ·Atherosclerosis Supplements ·M. John Chapman,Henry N. Ginsberg,Pierre Amarenco,(unknown),Jan Borén,Alberico L. Catapano,Olivier Descamps,Edward A. Fisher,Petri T. Kovanen,J.A. Kuivenhoven,Philippe Lesnik,L. Masana,Børge G. Nordestgaard,Kausik K. Ray,(unknown),Marja‐Riitta Taskinen,Lâle Tokgözoğlu,Anne Tybjærg‐Hansen,Gerald F. Watts	66
4	Identification and characterization of novel loss of function mutations in ATP-binding cassette transporter A1 in patients with low plasma high-density lipoprotein cholesterol 2010 ·Atherosclerosis ·(unknown),Alinda W.M. Schimmel,Jorge Peter,(unknown),Adriaan G. Holleboom,M. Vergeer,Robin P. F. Dullaart,Geesje M. Dallinga‐Thie,G. Kees Hovingh,(unknown),Tommaso Fasano,Letizia Bocchi,S. Calandra,J.A. Kuivenhoven,Mohammad Mahdi Motazacker	45
5	P216 CARRIERS OF LCAT GENE MUTATIONS HAVE INCREASED ATHEROSCLEROSIS: A 3.0 TESLA MRI STUDY 2010 ·Atherosclerosis Supplements ·Adriaan G. Holleboom,Raphaël Duivenvoorden,Bas van den Bogaard,E. de Groot,Aart J. Nederveen,Johan S. Laméris,J Kastelein,E.S.G. Stroes,J.A. Kuivenhoven	2
6	Elevated cholesteryl ester transfer protein concentration is associated with an increased risk for cardiovascular disease in women, but not in men, with Type 2 diabetes: the Hoorn Study 2007 ·Diabetic Medicine ·Marjan Alssema,Joost Dekker,J.A. Kuivenhoven,Giel Nijpels,Tom Teerlink,P Scheffer,M. Diamant,Coen D.A. Stehouwer,L.M. Bouter,Robert J. Heine	10
7	Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study 2006 ·Journal of Lipid Research ·Stefan F.C. Vaessen,Frank G. Schaap,J.A. Kuivenhoven,Albert K. Groen,Barbara A. Hutten,S. Matthijs Boekholdt,Hiroaki Hattori,Manjinder S. Sandhu,Sheila Bingham,Robert Luben,Jutta Palmen,Nicholas J. Wareham,Steve E. Humphries,John J.P. Kastelein,Philippa J. Talmud,Kay‐Tee Khaw	72
8	Mo-P1:109 LDL particle number and risk for future cardiovascular risk 2006 ·Atherosclerosis Supplements ·(unknown),Wim A. van der Steeg,S. Matthijs Boekholdt,(unknown),James D. Otvos,J.A. Kuivenhoven,Sheila Bingham,(unknown),Kon Taik Khaw,John J.P. Kastelein	1
9	We-W45:6 Apolipoprotein AV, triglycerides and risk of future coronary artery disease in apparently healthy men and women; the EPIC-Norfolk population study 2006 ·Atherosclerosis Supplements ·Stefan F.C. Vaessen,Frank G. Schaap,J.A. Kuivenhoven,A.K. Groen,Barbara A. Hutten,S. Matthijs Boekholdt,Manjinder S. Sandhu,Steve E. Humphries,Philippa J. Talmud,Kay‐Tee Khaw	2
10	Mo-P3:223 Optimization of adeno-associated virus mediated apolipoprotein A-I gene delivery to the murine liver to assess effects on atherosclerosis 2006 ·Atherosclerosis Supplements ·Stefan F.C. Vaessen,Robert Jan Veldman,(unknown),Jolanda Snapper,(unknown),John J.P. Kastelein,Jaap Twisk,J.A. Kuivenhoven	1
11	Mo-W7:5 Myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals 2006 ·Atherosclerosis Supplements ·Marijn C. Meuwese,S. Matthijs Boekholdt,J.J.P. Kastelein,Stanley L. Hazen,J.A. Kuivenhoven,(unknown),Nicholas J. Wareham,Robert G. Schaub,(unknown),(unknown)	1
12	CETP gene variation: relation to lipid parameters and cardiovascular risk 2004 ·Current Opinion in Lipidology ·S. Matthijs Boekholdt,J.A. Kuivenhoven,G. Kees Hovingh,J. Wouter Jukema,John J.P. Kastelein,Arie van Tol	53
13	Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS) 2004 ·European Journal of Clinical Investigation ·Anke H.E.M. Klerkx,Greetje J. de Grooth,Aeilko H. Zwinderman,J. Wouter Jukema,J.A. Kuivenhoven,John J.P. Kastelein	76
14	Plasma Levels of Cholesteryl Ester Transfer Protein and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women 2004 ·Circulation ·S. Matthijs Boekholdt,J.A. Kuivenhoven,Nicholas J. Wareham,Ron J.G. Peters,J. Wouter Jukema,Robert Luben,Sheila Bingham,Nicholas Day,John J.P. Kastelein,Kay‐Tee Khaw	157
15	Heterozygosity for ABCA1 gene mutations: effects on enzymes, apolipoproteins and lipoprotein particle size 2003 ·Atherosclerosis ·J.A. Kuivenhoven,G. Kees Hovingh,Arie van Tol,Matti Jauhiainen,Christian Ehnholm,Jean‐Charles Fruchart,Eliot A. Brinton,James D. Otvos,A.H.M. Smelt,A. Brownlee,Aeilko H. Zwinderman,Michael R. Hayden,John J.P. Kastelein	16
16	Lipid-free apolipoprotein (apo) A-I is converted into alpha-migrating high density lipoproteins by lipoprotein-depleted plasma of normolipidemic donors and apo A-I-deficient patients but not of Tangier disease patients 1998 ·Atherosclerosis ·Arnold von Eckardstein,Yadong Huang,John J.P. Kastelein,Jürgen Geisel,José T. Real,J.A. Kuivenhoven,Roberto Miccoli,G Noseda,Gerd Assmann	12
17	A unique genetic and biochemical presentation of fish-eye disease. 1995 ·Journal of Clinical Investigation ·J.A. Kuivenhoven,(unknown),Heiko Wiebusch,Santica M. Marcovina,Harald Funke,Gerd Assmann,P. Haydn Pritchard,John J.P. Kastelein	45
18	Fish Eye Disease and LCAT-deficiency, extremes of one phenotype. A novel LCAT-mutation in a large family of Dutch descent 1994 ·Atherosclerosis ·J.A. Kuivenhoven,Heiko Wiebusch,(unknown),John S. Hill,P. Haydn Pritchard,Harald Funke,J Kastelein	2

About J.A. Kuivenhoven

J.A. Kuivenhoven is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Nephrology, having authored 18 papers that have together received 595 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (11 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Cholesterol and Lipid Metabolism (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (340 citations), Surgery (439 citations) and Cancer Research (131 citations). J.A. Kuivenhoven has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include John J.P. Kastelein, J. Wouter Jukema, S. Matthijs Boekholdt, Sheila Bingham, Robert Luben, Kay‐Tee Khaw, Nicholas J. Wareham, Nicholas Day, Ron J.G. Peters and Aeilko H. Zwinderman. Their work appears in journals such as Circulation, Journal of Clinical Investigation and Journal of Lipid Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact